<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7019903/results/search/test_trace/results.xml">
  <result pre="ribavirin. Currently, there are no FDA approved drugs for the" exact="treatment" post="of orthohantavirus infections. Antiviral activities and cytotoxicity profiles suggest"/>
  <result pre="could be promising candidates for further investigation as a potential" exact="treatment" post="of hantaviral diseases. orthohantavirus phenyl-benzotriazoles antiviral activity C-FRA 1."/>
  <result pre="Over the last few years, the search for an effective" exact="treatment" post="for orthohantaviruses infections has undergone a considerable increase [7]."/>
  <result pre="and Russia [11], clinical trials have been conducted for the" exact="treatment" post="of HFRS using post-exposure, intravenous RBV but while significant"/>
  <result pre="Administration (FDA) granted antivirals [14], vaccines, or immunotherapeutic for the" exact="treatment" post="of HFRS or HPS, and consequently, therapeutic approaches are"/>
  <result pre="further investigate if these derivatives are able to inhibit viral" exact="infection" post="processes of other negative sense RNA virus families, we"/>
  <result pre="families, we subjected them (Figure 1) to a broad antiviral" exact="screening" post="including the Hantaan virus (HTNV), a segmented RNA virus"/>
  <result pre="interesting EC50 values, so we performed the same broad antiviral" exact="screening" post="on a series of 2-phenyl-benzotriazole from our library (3k-n"/>
  <result pre="of the active compound during a single round of viral" exact="infection" post="was determined. Treatment with non-cytotoxic 20 µM concentration of"/>
  <result pre="viral titer of HTNV was also observed at 50 µM" exact="treatment" post="of RBV (* p-value &amp;lt;0.05, unpaired t-test). VeroE6 cells"/>
  <result pre="inhibitors. The production of the virus was significantly reduced upon" exact="treatment" post="with 2l (3,08 log10). The same trend of reduction"/>
  <result pre="FDA approved antivirals, vaccines, or immunotherapeutic agents available for the" exact="treatment" post="of HFRS or HPS. The objective of this study"/>
  <result pre="starting point for the development of second-generation effective candidates for" exact="treatment" post="against orthohantavirus infections. Acknowledgments The authors are highly grateful"/>
  <result pre="Infect. Dis.19911641119112710.1093/infdis/164.6.11191683355 11.MalininO.V.PlatonovA.E.Insufficient efficacy and safety of intravenous ribavirin in" exact="treatment" post="of haemorrhagic fever with renal syndrome caused by puumala"/>
  <result pre="Selective Inhibitors of Coxsackies B5 virus: 1-[4-(5,6-dimethyl(H)-1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureaMed. Chem.202016110.2174/1573406416666191226142744 22.HeiderH.ZiajaB.PriemerC.LundkvistA.NeytsJ.KrügerD.H.UlrichR.A chemiluminescence" exact="detection" post="method of hantaviral antigens in neutralisation assays and inhibitor"/>
 </snippets>
</snippetsTree>
